Anteris Technologies Global Corp.

NASDAQ:AVR

Medical - Devices

Healthcare
$5.21 -0.16%

-$0.02 today

Market cap
$507.94M
Beta
0.73
P/E (TTM)
-2.3
EPS (TTM)
-$4.04
52W Low $2.85High $10.14

Volume 1.24M

Average 1.18M

AVR Interest Expense

Cost of servicing the company's debt during the period.

Anteris Technologies Global Corp.NASDAQ: AVR

Interest Expense · Q1 FY2026 · quarter ended Mar 2026

Interest expense growth accelerates

Q1 FY2026 interest expense of $27K rose 3.8% year over year, ahead of the -18.3% change in trailing-twelve-month interest expense. Sequentially, it rose 170.0% from the prior quarter. Over 3 fiscal years it compounded at -51.7% a year.

Context

  • Interest expense amounted to 3.8% of revenue in FY2025, up 0.8 pp from a year earlier.
  • Interest expense increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +3.8% holds above the trailing-twelve-month pace of -18.3%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$27K+170.0% QoQ
Last fiscal yearDec 2025
$73K-11.0% YoY
LTMMar 2026
$74K-18.3% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.8%——
1 year-11.0%——
3-year CAGR-51.7%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
73K USD
Year-over-year change
-11.0%
4-year CAGR
-48.5%

Interest Expense vs competitors

How AVR compares with its peers on the latest reported figures

  • AVR's LTM Mar 2026 interest expense of $74K is the 5th highest of the 6 companies compared; the peer median is $43.28M.
  • Its year-over-year change of -18.3% is the 3rd highest of 5, against a peer median of -14.6%.
  • Interest expense amounts to 4.0% of revenue for AVR, versus a peer median of 1.9%.
AVR Competitors Peer median
Interest Expense for AVR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$725M -1.8%+4.0%1.9%
BSXBoston Scientific CorporationLTM Jun 2026$363M -9.0%-9.1%1.7%
LIVNLivaNova PLCLTM Sep 2026$43.28M -20.1%+0.7%2.9%
AORTArtivion, Inc.LTM Mar 2026$24.29M -28.8%+13.4%5.3%
AVRAnteris Technologies Global Corp.LTM Mar 2026$74K -18.3%-51.7%4.0%
EWEdwards Lifesciences CorporationLTM Jun 2026$0 ——0.0%
Peer median (excluding AVR) $43.28M-14.6%+2.3%1.9%

Competitors are the stored peer set for AVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue5.83M3.2M2.73M2.7M1.91M
Cost of Revenue3.93M2.9M1.86M1.44M2.23M
Gross Profit1.91M298.38K876.8K1.27M(317K)
Gross Margin32.7%9.3%32.1%46.8%-16.6%
Research & Development9.99M17.59M31.02M51.45M69.12M
Selling, General & Admin9.14M15.21M17.05M024.46M
Operating Expenses18.77M31.41M49.02M79.64M93.58M
Depreciation & Amortization640.09K774.08K1.16M1.51M1.66M
EBITDA(15.5M)(29.14M)(45.54M)(74.38M)(92.49M)
EBITDA Margin-265.8%-910.5%-1665.1%-2751.7%-4834.9%
Operating Income(16.86M)(31.11M)(48.14M)(78.37M)(93.89M)
Operating Margin-289.2%-972.1%-1760.3%-2899.4%-4908.2%
Interest Income68.55K210.38K428.06K0709K
Interest Expense1.03M648.71K67.09K82K73K
Other Income / Expenses(310.48K)550.48K1.38M2.41M(331K)
Income Before Tax(17.17M)(30.56M)(46.76M)(75.97M)(94.23M)
Pre-Tax Margin-294.5%-954.9%-1709.9%-2810.5%-4925.5%
Income Tax Expense00000
Net Income(17.17M)(30.56M)(46.02M)(76.29M)(94.14M)
Net Margin-294.5%-954.9%-1682.8%-2822.5%-4921.3%
EPS (Basic)(0.48)(0.85)(1.28)(3.77)(4.00)
EPS (Diluted)(0.48)(0.85)(1.28)(3.77)(4.00)
Weighted Avg Shares35.94M35.94M35.94M20.25M23.58M
Weighted Avg Shares (Diluted)35.94M35.94M35.94M20.25M23.58M

Anteris Technologies Global Corp.

NASDAQ:AVR

Intrinsic Alpha fair value

Locked

Current Price

$5.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.